Life Sciences
USA Guide 2024 : Massachusetts
Band 2
About
Provided by Foley Hoag LLP
Our nationally recognized Life Sciences practice can help you navigate the issues associated with the development and commercialization of innovative medical products and services.
We have substantial experience throughout all areas of the industry including on behalf of biotechnology, pharmaceutical, medical device and healthcare services companies, medical-research institutes and patient organizations. Our international life science client base consists of companies in all stages of development, from startups to Fortune 50 companies. Drawing on the talents of a wide variety of professionals, many of whom have had previous careers as scientists, MDs and high-ranking government officials, we can help you to navigate the complex waters associated with the development, approval, commercialization, reimbursement and coverage of innovative medical products and services.
Key Stats:
- 2,000 public and private clients, representing all facets of the life sciences industry
- $50B+ in life sciences-related deal activity for clients over the last ten years
- 1/3 of the firm's work is focused on the life science community, making it our largest sector
Sector Expertise:
- Biotechnology
- Pharmaceuticals
- Diagnostics & Precision Medicine
- Medical Device, Instruments & Analytics
- Healthtech & Digital Health
Chambers Review
Foley Hoag's Massachusetts-based team provides extensive support to clients in the life sciences sector. The group has a wealth of experience advising early-stage companies on matters including IPOs, venture capital financing and patent management and prosecution.
Jeffrey Quillen is a key contact.
Work Highlights
- Foley Hoag represented Vaxess Technologies in connection with a $27 million Series B financing.